Thyrocare Technologies Q2 Results FY27: PAT Falls 66.89% to Rs 15.89 Cr, Revenue Rs 270.81 Cr

Thyrocare Technologies Ltd (THYROCARE) Q2 Results FY27 announced on 29 October 2026, covering the company's financial performance for the July to September quarter. Thyrocare Technologies Q2 Results FY27 show revenue of Rs 270.81 Cr and PAT of Rs 15.89 Cr, each measured against the same quarter a year earlier. The results date also marks the point from which investors can compare the two lines against the prior-year figures.

This Univest results analysis of Thyrocare Technologies Q2 Results covers the financial highlights, business drivers, outlook and risks behind the numbers. It starts with the Financial Highlights and then moves through each section in turn, using only the figures supplied with the filing.

Click Here – Get Free Investment Predictions

Thyrocare Technologies Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 270.81 Cr	Rs 216.53 Cr	+25.07% YoY
Net Profit (PAT)	Rs 15.89 Cr	Rs 47.99 Cr	-66.89% YoY

Source: company filing for Thyrocare Technologies Q2 Results FY27, 29 October 2026. Figures in Rs Crore.

Key Takeaways from Thyrocare Technologies Q2 Results: What Stands Out

• Revenue rose 25.07% YoY to Rs 270.81 Cr from Rs 216.53 Cr, which is clear YoY growth in the top line for the quarter.
• Net profit fell 66.89% YoY to Rs 15.89 Cr from Rs 47.99 Cr, moving in the opposite direction to revenue.
• Net profit margin narrowed to 5.9% from 22.2% in the comparison quarter, as profit fell while revenue grew.
• Return on equity of 29.05% and return on capital employed of 38.30% are the FY26 return figures recorded alongside this quarter.
• Thyrocare Technologies Q2 Results FY27 are examined further in the performance analysis, which sets the revenue and profit moves side by side.

Thyrocare Technologies Q2 Results FY27: Performance Analysis

Thyrocare Technologies reported revenue of Rs 270.81 Cr for July to September 2026, up 25.07% from Rs 216.53 Cr a year earlier, while net profit fell 66.89% to Rs 15.89 Cr from Rs 47.99 Cr. In absolute terms, revenue increased by Rs 54.28 Cr and net profit decreased by Rs 32.10 Cr.

The Thyrocare Technologies Q2 Results FY27 results analysis shows the two lines moving apart. Revenue added Rs 54.28 Cr over the year, yet net profit retained a smaller share of it, which is why the margin figure of 5.9% sits well below the 22.2% recorded a year earlier.

For Thyrocare Technologies Q2 Results, the supplied data confirms what changed in revenue and net profit but does not establish the specific cause of the profit decline. Investors reading the quarterly results will want to track whether later filings narrow the gap between the two lines, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points first to revenue, which grew 25.1% year on year to Rs 270.81 Cr in the latest quarter. This growth is the disclosed driver behind the top line in Thyrocare Technologies Q2 Results FY27.

Return Ratios – Return on equity was 29.05% in FY26 and return on capital employed was 38.30% in FY26. These full-year figures sit beside the latest quarterly results and describe the returns earned on the capital in the business.

Debt Position – The company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26. This means the balance sheet carried almost no borrowings at the last full-year mark, a point that frames the FY27 outlook.

FY27 Outlook After Thyrocare Technologies Q2 Results

No management guidance accompanies the filing of 29 October 2026, the results date, so the FY27 picture rests on what the coming quarters report. Full-year FY27 results will depend on how revenue and net profit develop from here, starting from the Rs 270.81 Cr and Rs 15.89 Cr recorded for the second quarter.

In this results analysis of Thyrocare Technologies Q2 Results FY27, the figures to watch in later filings are the revenue trend, which grew 25.07% YoY this time, and net profit, which stood at Rs 15.89 Cr. Each of these can be checked against the Financial Highlights table before the next filing is read. The risks that could shape those figures are set out next.

Key Risks to Watch After Thyrocare Technologies Q2 Results FY27

Net Profit Decline

Net profit fell 66.9% year on year to Rs 15.89 Cr. A lower net profit figure is the first item to monitor, because it sits against revenue that moved up over the same period.

Narrower Net Profit Margin

Net profit margin narrowed to 5.9% from 22.2% in the comparison quarter. After Thyrocare Technologies Q2 Results FY27, the gap between YoY growth in revenue and the profit line is the metric investors can follow in each new filing.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 15.89 Cr to Rs 52.19 Cr over the last 5 quarters. The latest quarter sits at the low end of that range, so each new filing deserves a close reading.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Thyrocare Technologies Q2 Results FY27 present revenue of Rs 270.81 Cr, up 25.07% YoY, and net profit of Rs 15.89 Cr, down 66.89%. These quarterly results show a wider gap between the two lines than a year earlier. Within Thyrocare Technologies Q2 Results, Univest keeps to the supplied figures, and investors should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Thyrocare Technologies Q2 Results FY27

What are Thyrocare Technologies Q2 Results FY27?

Ans. Thyrocare Technologies Q2 Results FY27 cover July to September 2026, with revenue of Rs 270.81 Cr and net profit of Rs 15.89 Cr. Alongside this, the Quick Answer box summarises how both lines moved against the prior year.

What is the results date for Thyrocare Technologies Q2 Results FY27?

Ans. Thyrocare Technologies declared its Q2 FY27 results on 29 October 2026. This results date matters because every YoY comparison in the Financial Highlights table is drawn from that filing.

What revenue was reported in Thyrocare Technologies Q2 Results FY27?

Ans. Thyrocare Technologies reported revenue of Rs 270.81 Cr for the quarter, compared with Rs 216.53 Cr a year earlier, which means revenue increased by Rs 54.28 Cr, as the Performance Analysis explains.

What net profit was reported in Thyrocare Technologies Q2 Results FY27?

Ans. Thyrocare Technologies reported net profit of Rs 15.89 Cr, compared with Rs 47.99 Cr in the same quarter last year, which means a fall of Rs 32.10 Cr, detailed in the Performance Analysis.

How much YoY growth did revenue show in Thyrocare Technologies Q2 Results FY27?

Ans. Thyrocare Technologies Q2 Results FY27 show revenue growth of 25.07% YoY. Compared with this, net profit moved down 66.89%, a contrast covered in the Key Takeaways section of the article.

Did net profit rise or fall in Thyrocare Technologies Q2 Results?

Ans. Thyrocare Technologies Q2 Results show net profit falling 66.89% YoY to Rs 15.89 Cr from Rs 47.99 Cr, while revenue rose 25.07%, as the Key Takeaways section sets out.

What was the net profit margin in Thyrocare Technologies Q2 Results FY27?

Ans. Thyrocare Technologies recorded a net profit margin of 5.9% in the quarter, compared with 22.2% in the comparison quarter, which means the margin narrowed, a point raised in the Key Risks section.

Which quarter do Thyrocare Technologies Q2 Results cover?

Ans. Thyrocare Technologies Q2 Results cover the July to September 2026 quarter of FY27. Alongside this, the article compares each figure with the same quarter a year earlier, as the Financial Highlights table shows.

What business factors shaped Thyrocare Technologies Q2 Results FY27?

Ans. The disclosed factors are revenue growth of 25.1% year on year, FY26 return on equity of 29.05%, return on capital employed of 38.30% and a 0.00 debt-to-assets ratio, as the Key Business Factors section notes.

What are the key risks after Thyrocare Technologies Q2 Results FY27?

Ans. The supplied risks in the quarterly results are the 66.9% net profit decline, the narrower 5.9% net profit margin and volatile quarterly net profit, so each is explained under Key Risks to Watch in the article.

What is the outlook after Thyrocare Technologies Q2 Results?

Ans. No management guidance came with the filing, so FY27 full-year results will depend on later quarters. Alongside this, the FY27 Outlook section lists the revenue YoY growth and net profit trends to follow.

Where can I find the complete Thyrocare Technologies Q2 Results FY27 data?

Ans. The complete revenue and net profit data sits in the Financial Highlights table of this Univest article, which means every figure here can be checked against the filing released on the 29 October 2026 results date.